Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and

Pierre-Emmanuel Rautou1, Aurélie S Leroyer, Bhama Ramkhelawon

  • 1Paris Centre de recherche Cardiovasculaire à l'HEGP, INSERM U970, 56, rue Leblanc, 75737 Paris cedex 15, France. chantal.boulanger@inserm.fr.

Circulation Research
|December 18, 2010
PubMed
Abstract

Insights

Microparticles (MPs) from atherosclerotic plaques transfer intercellular adhesion molecule-1 (ICAM-1) to endothelial cells, increasing monocyte adhesion and promoting plaque progression. Symptomatic plaque MPs are more potent drivers of this inflammatory process.

Area of Science:

  • Cardiovascular Biology
  • Cell Biology
  • Immunology

Background:

  • Submicron microparticles (MPs) shed from activated or apoptotic cells accumulate in atherosclerotic plaques.
  • These plaque-derived MPs contribute to endothelial proliferation and neovascularization.

Purpose of the Study:

  • To investigate if MPs from human atherosclerotic plaques enhance endothelial expression of adhesion molecules.
  • To determine if these plaque MPs increase monocyte recruitment to the endothelium.

Main Methods:

  • Human umbilical vein and coronary artery endothelial cells were treated with MPs from human atherosclerotic plaques (n=62).
  • Intercellular adhesion molecule-1 (ICAM-1) levels, mRNA, and transfer were assessed.
  • Monocyte adhesion assays were performed in static and flow conditions using human and mouse models.

Main Results:

  • Plaque MPs, not circulating MPs, significantly increased endothelial ICAM-1 levels (3.4-fold) in a concentration-dependent manner.
  • Plaque MPs transferred functional ICAM-1 to endothelial cells, enhancing monocyte adhesion.
  • MPs from symptomatic plaques showed greater potency in stimulating monocyte adhesion compared to those from asymptomatic plaques.

Conclusions:

  • MPs from human atherosclerotic plaques facilitate monocyte recruitment by transferring ICAM-1 to endothelial cells.
  • These findings suggest that plaque-derived MPs play a critical role in the progression of atherosclerotic plaques.